Streetbeat News

Stock Prices

MGRX

Mangoceuticals, Inc. (NASDAQ:MGRX) shares surged after the company announced the development of oral formulations of Semaglutide and Tirzepatide for weight management. The products, named 'Slim' and 'Trim', are expected to be available in the 3rd quarter of the year.

Portfolio Pulse from Erica Kollmann

May 21, 2024 | 2:56 pm

LOW

Lowe's shares are trading lower after the company reported Q1 financial results. The stock initially traded higher, but it has since reversed.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 2:53 pm

LLY

NVO

Novo Nordisk's CEO commented on Eli Lilly's diabetes drug approval in China, highlighting increased competition in the market. He assured that there is no shortage of Novo Nordisk's Ozempic in the U.S. and emphasized the company's focus on providing high-quality products amid compounded versions of Semaglutide.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 2:53 pm

AZO

AutoZone shares are trading lower after the company reported worse-than-expected Q3 sales results.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 2:51 pm

JPM

JP Morgan CEO Jamie Dimon announced during the annual shareholder meeting that the company is not expecting a stock split in the foreseeable future.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 2:50 pm

MGRX

Mangoceuticals shares have resumed trading after a temporary halt. This development is significant for investors as it may impact the stock's short-term price movement.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 2:49 pm

SNOW

Investors have taken a bearish stance on Snowflake (NYSE:SNOW) as indicated by unusual options activity. Benzinga's options scanner detected 9 uncommon options trades, with 55% of the sentiment being bearish. The major market movers are focusing on a price band between $90.0 and $200.0 for Snowflake. The stock is currently trading at $163.8, down by -0.59%, with an anticipated earnings release in 1 day. Analysts have mixed ratings with an average price target of $218.33.

Portfolio Pulse from Benzinga Insights

May 21, 2024 | 2:46 pm

SHOP

Recent unusual options activity for Shopify (NYSE:SHOP) indicates a bullish stance among big-money traders, with 12 call options and 1 put option detected. The overall sentiment is 53% bullish and 23% bearish. The price range focus is between $25.0 and $95.0, with significant trades showing high interest in the stock.

Portfolio Pulse from Benzinga Insights

May 21, 2024 | 2:46 pm

CVS

Financial giants have made bearish moves on CVS Health, with 62% of recent options trades showing bearish tendencies. Analysts have mixed ratings, with price targets ranging from $58 to $77. CVS Health's stock is currently down 0.73% at $56.98.

Portfolio Pulse from Benzinga Insights

May 21, 2024 | 2:46 pm

BDRX

Biodexa Pharmaceuticals (NASDAQ:BDRX) stock is trading higher following positive results from its Phase 2 clinical trial of eRapa for Familial Adenomatous Polyposis. The trial showed a significant reduction in polyp burden and high non-progression rates, leading to a 78.4% increase in stock price.

Portfolio Pulse from Dylan Berman

May 21, 2024 | 2:45 pm